Search hospitals > Michigan > Kalamazoo

West Michigan Cancer Center

Claim this profile
Kalamazoo, Michigan 49007
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
572 reported clinical trials
2 medical researchers
Photo of West Michigan Cancer Center in KalamazooPhoto of West Michigan Cancer Center in Kalamazoo

Summary

West Michigan Cancer Center is a medical facility located in Kalamazoo, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. West Michigan Cancer Center is involved with conducting 572 clinical trials across 565 conditions. There are 2 research doctors associated with this hospital, such as Kathleen J. Yost and Gitonga Munene, MD.

Area of expertise

1Cancer
Global Leader
West Michigan Cancer Center has run 171 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
West Michigan Cancer Center has run 86 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at West Michigan Cancer Center

Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Pancreatic Cancer
Squamous Cell Carcinoma
Multiple Myeloma
Gastric Cancer
Ovarian Cancer
Image of trial facility.

Support Program

for Breast Cancer

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at West Michigan Cancer Center?
West Michigan Cancer Center is a medical facility located in Kalamazoo, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. West Michigan Cancer Center is involved with conducting 572 clinical trials across 565 conditions. There are 2 research doctors associated with this hospital, such as Kathleen J. Yost and Gitonga Munene, MD.
Where is West Michigan Cancer Center located?
The West Michigan Cancer Center is located at 200 N Park St. Kalamazoo, MI 49007, in downtown Kalamazoo. To reach us from South of Kalamazoo, take US-131 north to Business 131 (exit 36A-Stadium Drive), follow Business 131 to M-43 (W. Michigan), turn right onto M-43, continue to North Park, turn left onto North Park, and WMCC will be on your right.
Who should I call to ask about financial aid or insurance network?
**West Michigan Cancer Center Contact Information** **Financial Assistance:** - **Phone:** (616) 954-9800 or (800) 411-7999 - **Website:** Visit for resources and insurance forms. **Insurance and Billing:** - **Phone:** (269) 373-0148 - **Email:** billing@wmcc.org - **Note:** They work with many insurance plans and will bill your insurance. Remaining charges after insurance are the patient's responsibility. **Additional Resources:** - **Medicare:** (800) 633-4227, www.Medicare.gov - **Medicaid:** (855) 275-6424, www.Medicaid.gov - **Veterans Benefits:** (800) 827-1000, www.va.gov/service-member-benefits/ - **Social Security Disability:** (800) 772-1213, www.ssa.gov/applyfordisability/ - **Supplemental Security Income:** (800) 772-1213, www.ssa.gov/benefits/ssi/ **Medical Social Work and Dietitian Services:** - **Medical Social Workers:** (269) 384-8629, socialwork@wmcc.org - **Registered Dietitians:** (269) 373-0109, nutrition@wmcc.org
What insurance does West Michigan Cancer Center accept?
The West Michigan Cancer Center accepts a wide range of insurance plans, including but not limited to Aetna, Blue Cross Blue Shield of Michigan, Cigna-Priority Health Strategic Alliance, Humana Medicare HMO & PPO, McLaren Health Plans, Meridian Medicare, Molina Healthcare, Priority Health, TriCare, United Health Care, and VA/VACCN Optum. For a comprehensive list of accepted insurance plans, it is recommended to contact the center directly. This ensures that your specific insurance plan is accepted.
What awards or recognition has West Michigan Cancer Center received?
The West Michigan Cancer Center, located in Kalamazoo, Michigan, is a recognized National Cancer Institute Community Oncology Research Program (NCORP) site, offering access to advanced clinical cancer trials. It holds accreditations from the American Society of Clinical Oncology (ASCO) and the American College of Radiation Oncology (ACRO), underscoring its dedication to excellence in care and research.